Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum PsyBio Therapeutics Corp V.PSYB.H

Alternate Symbol(s):  PSYBF

Healthcare Biotechnology
PsyBio Therapeutics Corp. is a Canada-based biotechnology company. The Company is focused on discovering, designing and developing psycho-focused therapeutics to improve mental and neurological conditions. It is focused on understanding the value of tryptamines and other related psycho-targeted molecules as therapeutic candidates to improve mental and neurological health. The Company is engaged... see more

TSXV:PSYB.H - Post Discussion

PsyBio Therapeutics Corp > $ORIG Investee TripSitter Trading on CSE
View:
Post by partystocker on Dec 07, 2021 2:28pm

$ORIG Investee TripSitter Trading on CSE

Origin Therapeutics’ (soon to IPO under the ticker $ORIG) portfolio company TripSitter commenced trading on the CSE late November. 


Tripsitter has seen tremendous growth in the past year, and this public listing is an exciting opportunity for the company to continue to fuel its trajectory. Tripsitter is a consultative virtual clinic and telehealth platform that connects prospective patients to a licensed physician in the United States who can evaluate for a prescribed treatment program of low-dose, oral ketamine medication.


The therapeutic psychedelics industry has me quite intrigued as it seems to me to be one of the most promising cutting edge approaches to the treatment of mental health currently. With TripSitter working towards harnessing the strengths of telemedicine into this industry the growth opportunity for the company seems exponential. 


Looking forward to watching $ORIG’s performance once they go public, as the industry is ripe to see growth once regulations on psychedelics are lifted for use as widespread clinical treatments. 


https://finance.yahoo.com/news/origin-therapeutics-portfolio-company-tripsitter-120000288.html

 
Be the first to comment on this post
PsyBio Therapeutics Corp